CMI Communications

Full (lovely) story: these commentaries are peer-reviewed. First submission authored by Llor & Kjaer. A reviewer suggests they contact Prof Gram (granddaughter of HC Gram). They do. She contributes meaningfully & they feel it only right to make her last author. @gurujosh.bsky.social #IDSky #microsky

📣 Official ESCMID statement on #MMR vaccine "There is no evidence that administering measles, mumps & rubella #vaccines separately confers any immunological or safety advantage over the combined MMR vaccine" www.cmi-comms.org/article/S295... @escmid.bsky.social @idsainfo.bsky.social #IDSky #medsky

Hot off the press from CLARITY! 🎉 Led by @angelahuttner.bsky.social with @steventong.bsky.social, @gurujosh.bsky.social and Tom Holland clarityinitiative.org/commentaries... #IDsky #clarity @cmicomms.bsky.social

🎙️ Just published Communicable E65: Quarterly catch-up Hosted by Emily McDonald and Angela Huttner 🌟 Listen on #Communicable: https://share.transistor.fm/s/23201715 #IDSky #clinmicro

📣 New #Communicable drops Mon 19 Oct! Emily McDonald and Angela Huttner sit down for another Quarterly catch-up, discussing four recent RCTs across different patient populations and infections, and what the findings mean for clinical practice. #IDSky #clinmicro

🎙️ Just published Communicable E64: Getting micro on macrolides for community-acquired pneumonia Hosted by Marc Bonten & Emily McDonald with invited guests Valentijn Schweitzer & Sylvain Lother 🌟 Listen on #Communicable: https://share.transistor.fm/s/deec5589 #IDSky #clinmicro

📣 New #Communicable drops Mon 05 Oct! Marc Bonten & Emily McDonald are joined by Valentijn Schweitzer & Sylvain Lother to discuss the use of macrolides in community-acquired pneumonia and how the available evidence informs clinical practice. Tune in! #IDSky #clinmicro

📣 More evidence that less is probably more: During a global shortage of #bloodculture bottles, Japanese hospitals reduced the number of sets drawn per patient. Contamination rates went down, while detection rates of real pathogens did not. #IDSky #clinmicro www.cmi-comms.org/article/S295...

The next Clarity commentary. On the SNAP trial. Neither I nor @gurujosh.bsky.social had anything to do with this commentary (deliberately). Conclusions though are in line with my interpretation of the data. i.e., use cefazolin for MSSA bacteremia. @angelahuttner.bsky.social @cmicomms.bsky.social

Really appreciate the depth that Communicable provides to these studies. It’s context, nuance, applicability, everything 🥰

So excited for this episode, as we head into the northern hemisphere flu season... the first few cases now coming into our hospital... what do we do... 🤔 🤷 #IDsky #clinmicro

🎙️ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results' Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong 🌟 Listen on #Communicable https://ow.ly/pJAO50ZOfK8 or on #Breakpoints https://ow.ly/p8Ti50ZOfK9 #IDSky #ViroSky #flu

📣 New #Communicable / #Breakpoints drops Mon 21 Sep! Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs. #IDSky #ViroSky #flu

💡 Take your clinical trial from concept to completion. Learn how to design, conduct and report a clinical trial through expert-led sessions and workshops covering every stage of the clinical trial journey. Register today: https://ow.ly/lStL50Zrgqa #IDSky CMI Communications CLARITY_Initiative

🎙️ Just published Communicable E62: the 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis Hosted by Emily McDonald & Josh Davis with invited guests Henning Bundgaard and Sami El-Dalati 🌟 Listen on #Communicable: https://share.transistor.fm/s/d5eb49ac #IDSky

📣 New #Communicable drops Mon 03 Sep! Emily McDonald & Josh Davis are joined by Henning Bundgaard & Sami El-Dalati to revisit the POET trial and discuss the ‘prose’ and cons of early oral switch for #endocarditis as well as challenges of implementing new evidence against long-standing dogma.

🎙️ Just published Communicable E61: We will make you love PK/PD, part 3 Hosted by Amy Legg, Rekha Pai & Angela Huttner with invited guests Amanda Gwee (@amandagwee.bsky.social) & Sebastian Wicha 🌟 Listen on #Communicable: https://share.transistor.fm/s/c4af55ab #IDSky #clinmicro

📣New #Communicable drops Mon 24 Aug. Amy Legg, Rekha Pai & Angela Huttner are back for the third part of the 'We will make you love PK/PD' series! @amandagwee.bsky.social & Sebastian Wicha join them to discuss model-informed precision dosing (#MIPD) that can support individualised dosing decisions.

🔥Wow. Our article is published with the legend @bradspellberg.bsky.social 🎉🔥 A journey that started with a simple question: What’s in a name? Today, I’m incredibly grateful to see our article published in @cmicomms.bsky.social EnJoy! #idsky www.cmi-comms.org/article/S295...

📣We rely more & more on #AI for literature review So how did 6 large language models compare to humans when extracting data from #RCTs for a systematic review? Not very well: overall #LLM concordance was 0.58-0.75. #IDSky @steventong.bsky.social @seanong.bsky.social cmi-comms.org/article/S295...

📣We rely more & more on #AI for literature review So how did 6 large language models compare to humans when extracting data from #RCTs for a systematic review? Not very well: overall #LLM concordance was 0.58-0.75. #IDSky @steventong.bsky.social @seanong.bsky.social cmi-comms.org/article/S295...

New antibiotics may reach patients faster, but approval is only the beginning. The latest REVIVE Antimicrobial Viewpoint by Ursula Theuretzbacher explores why coordinated, adaptive post-approval evidence generation is essential. 🔗 tinyurl.com/yyhuvjff Developed in collab with @cmicomms.bsky.social

🎙️ Just published Communicable E60: Quarterly catch-up Hosted by Emily McDonald and Erin McCreary, PharmD 🌟 Listen on #Communicable: https://share.transistor.fm/s/eac54f9c #IDSky #clinmicro

📣 New #Communicable drops Mon 10 Aug! Emily McDonald and Erin McCreary, PharmD host Quarterly catch-up to review new studies: when post-transplant is PCP likely to occur? How did procalcitonin do in the BALANCE trial? How did cefepime–nacubactam do vs imipenem in cUTI patients?🎙️ #IDSky #clinmicro

📣In a prospective nationwide Danish cohort of adults with #VZV #encephalitis: - fever was present at admission in only 39% - early receipt (<6h) of #acyclovir did not reduce mortality or significantly improve other outcomes at 6 months #IDSky #clinmicro #virosky www.cmi-comms.org/article/S295...

📣 In a prospective nationwide Danish cohort of adults with #VZV #encephalitis: - fever was present at admission in only 39% - early receipt (<6h) of #acyclovir did not reduce mortality or significantly improve other outcomes at 6 months #IDSky #virosky #virosky www.cmi-comms.org/article/S295...

🎙️ Just published Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain Hosted by Nav Narayanan & Thomas Tängdén with invited guests, Sören Gatermann, Christian Giske & Amy Mathers 🌟 Listen on #Communicable: https://share.transistor.fm/s/e2e4ad7e #IDSky #clinmicro

🎙️ Just published Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain Hosted by Nav Narayanan & Thomas Tängdén with invited guests, Sören Gatermann, Christian Giske & Amy Mathers 🌟 Listen on #Communicable: https://share.transistor.fm/s/e2e4ad7e #IDSky #clinmicro

📣 Q fever poses diagnostic and management challenges. This multinational position paper systematically assesses various countries' responses to #Qfever outbreaks and provides recommendations for future management. #IDSky #clinmicro #episky #Coxiella #zoonosis https://ow.ly/HeQx50ZsckH

Super interesting - great to see more examples that #microbiome imbalances have consequences beyond their immediate niches #UTISky #UTI

📣New #Communicable drops Mon 27 July! Kicking off our new 'Ask me anything' series, hosts Nav Narayanan & Thomas Tängdén invite EUCAST & CLSI leadership – Sören Gatermann, Christian Giske & Amy Mathers – to answer your questions on setting breakpoints, clarifying common misconceptions, and more! 🎙️

🔬 S. aureus bacteremia therapy webinar 📅 25 Aug 2026 • 13:00 CEST Hear new evidence from DOTS, early oral switch studies & the SNAP trial, plus key unanswered questions in SAB management us02web.zoom.us/webinar/regi... @heiman-wertheim.bsky.social @souhakanj.bsky.social @esgni-escmid.bsky.social

📣 The Dutch multidisciplinary guideline on community-acquired #pneumonia is out. Rational, GRADE-based recommendations for the diagnosis & treatment of #CAP requiring hospitalisation. (Sputum cultures & procalcitonin discouraged.) #IDSky #clinmicro www.cmi-comms.org/article/S295...

Infection prevention and control #IPC might not be sexy, but prevention is better than a cure. Therefore those Drs that prevent disease are saving lives, even if it doesn't appear to be very "glamorous" #IDEpi #MedSky

🎙️ Just published Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened Hosted by Angela Huttner & Josh Davis w/ guests Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack #IDSky #clinmicro Listen on #Communicable: https://share.transistor.fm/s/825e18f4

📣New #Communicable drops Mon 13 July! Angela Huttner & Josh Davis are joined by Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack to discuss the HAPPEN trial, a multicentre RCT showing impressive reductions in hospital-acquired #pneumonia, and the studies that led to it.🎙️ #IDSky #clinmicro

🎙️ Just published Communicable E57: We will make you love PK/PD, part 2 – quantitative methods Hosted by Thomas Tängdén and Rekha Pai with invited guests Iris Minichimayr (Austria) & Philip Selby (Australia) 🌟 Listen on #Communicable: https://share.transistor.fm/s/5edacc5d

🚀We're excited to share our latest Antimicrobial Viewpoint, developed collaboratively with @cmicomms.bsky.social. In 'From fixed courses to flexible care', the authors explore why antifungal treatment durations and routes deserve rethinking. 🔗Read the Viewpoint: revive.gardp.org/from-fixed-c...

📣 New #Communicable drops Monday, 29 June! 'We Will Make You Love PK/PD' series returns with part 2! Thomas Tängdén and Rekha Pai are joined by Iris Minichmayr and Philip Selby to discuss pharmacometrics, PK/PD modelling, and how these quantitative tools can support clinical decision-making. 🎙️

📣 Hughes et al perform molecular typing & whole-genome sequencing of #Staph aureus in patients with severe infections. #MSSA CC152 may be a new/under-recognized lineage in Europe causing #PVL positive necrotizing pneumonia & fasciitis. #IDSky #clinmicro #MedSky www.cmi-comms.org/article/S295...

🎙️ Just published Communicable E56: Frequentist vs Bayesian for clinical trial analysis – 99% probability you’ll want to listen to this Hosted by Emily McDonald & Josh Davis with invited guests Roger Lewis & Ian Marschner 🌟 Listen on #Communicable: https://share.transistor.fm/s/7ea020d2 #IDSky

📣 If you have questions about fosfomycin, we have answers! Excellent review article by Tiffany Wu, Kalpana Gupta, @erinmccreary.bsky.social, Sarah Turbett & Jacob Lazarus on oral #fosfomycin & how to use it. #IDSky #clinmicro #UTISky #Medsky #Pharmsky www.cmi-comms.org/article/S295...

📣 New #Communicable drops Monday, 15 June! Join hosts Josh Davis & Emily McDonald with guests Roger Lewis & Ian Marschner as they demystify Bayesian and frequentist statistical approaches in clinical trials, exploring key differences, common misconceptions, and surprising similarities. 🎙️ #IDSky

🎙️ Just published Communicable E55: Bonus episode – Bundibugyo Ebolavirus outbreak Hosted by Angela Huttner and Anne-Grete Märtson with invited guests Daniel Bausch and Martin Grobusch 🌟 Listen on #Communicable: https://share.transistor.fm/s/8750e095

🎙️ A special bonus episode of #Communicable is coming Monday Angela Huttner & Anne-Grete Märtson talk with Daniel Bausch & Martin Grobusch on how #Bundibugyo ebolavirus differs from Zaire & what to expect in the current outbreak #IDSky #Virosky #clinmicro https://ow.ly/nm5250Z7ViE

🎙️ Just published Communicable E54: ESCMID Global Late Breakers, part 2 Hosted by our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟 Listen on #Communicable: https://share.transistor.fm/s/a8cc04bb #ESCMIDGlobal2026 #IDSky #clinmicro

📣 Note to microbiologists & clinicians who need to isolate #Bordetella spp for antibiogram profiling: Klugherz et al. show that adding #vancomycin to #Regan-Lowe agar doubles the rate of isolation in culture #microsky #clinmicro #idsky #pertussis www.cmi-comms.org/article/S295...